Neuraxis NRXS
NYSE NRXS
$7.12 +0.03 (+0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Price to Sales (2023 - 2025)

Updated

Neuraxis' (NRXS) Price to Sales stood at 13.55 in Q4 2025, up 121.6% from 6.12 a year earlier and up 49.6% from the prior quarter.

Analysis

Neuraxis (NRXS) Price to Sales (2023 - 2025) Analysis & Trends

Starting with Q3 2023, Neuraxis' Price to Sales history includes 10 quarters.

  • Across earlier years, Price to Sales came in at 6.12 in FY2024 (+73.3%) and 3.53 in FY2023.
  • The Q4 2025 figure is the highest quarterly Price to Sales in data going back to Q3 2023.
  • On a year-over-year basis, Price to Sales rose in four of the last six quarters, with growth averaging 34.2%.
  • Per Business Quant, the preceding three quarters came in at 9.06 (Q3 2025), 7.42 (Q2 2025) and 5.29 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Neuraxis 88.77 Mn 64.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 13.55
Sep 30, 2025 9.06
Jun 30, 2025 7.42
Mar 31, 2025 5.29
Dec 31, 2024 6.12
Sep 30, 2024 8.47
Jun 30, 2024 8.39
Mar 31, 2024 8.94
Dec 31, 2023 3.53
Sep 30, 2023 5.42
API Access

Neuraxis Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=NRXS&period=max&api_key=YOUR_API_KEY